VTAK Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

1.17M

+1118.75%

Estimates Revision

The market is revising No Change the revenue expectations for Catheter Precision, Inc. (VTAK) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -29.20%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-29.20%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Catheter Precision Inc (VTAK.A) is -0.17, compared to its 5-year average forward P/E of -0.28. For a more detailed relative valuation and DCF analysis to assess Catheter Precision Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-0.28

Current PE

-0.17

Overvalued PE

-0.02

Undervalued PE

-0.55

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.58

Current PS

0.88

Overvalued PS

1.08

Undervalued PS

0.08

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

VTAK News & Events

Events Timeline

No data

News

7.5

2025-12-18Globenewswire

Catheter Precision Implements LockeT at Ireland's Largest EP Center

5.0

2025-12-01Globenewswire

Catheter Precision Launches LockeT Device in Switzerland with Positive Clinical Outcomes

9.5

2025-11-13Newsfilter

Catheter Precision (VTAK) Announces Q3 and Year-to-Date Results for 2025

People Also Watch

Frequently Asked Questions

What is Catheter Precision Inc (VTAK) stock price today?

The current price of VTAK is 2.025 USD — it has increased 1.25 % in the last trading day.

What is Catheter Precision Inc (VTAK)'s business?

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

What is the price predicton of VTAK Stock?

Wall Street analysts forecast VTAK stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for VTAK is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Catheter Precision Inc (VTAK)'s revenue for the last quarter?

Catheter Precision Inc revenue for the last quarter amounts to 226.00K USD, increased 135.42 % YoY.

What is Catheter Precision Inc (VTAK)'s earnings per share (EPS) for the last quarter?

Catheter Precision Inc. EPS for the last quarter amounts to -1.70 USD, decreased -95.55 % YoY.

What changes have occurred in the market's expectations for Catheter Precision Inc (VTAK)'s fundamentals?

How many employees does Catheter Precision Inc (VTAK). have?

Catheter Precision Inc (VTAK) has 22 emplpoyees as of January 09 2026.

What is Catheter Precision Inc (VTAK) market cap?

Today VTAK has the market capitalization of 3.38M USD.